Where does Autoimmune Technologies, LLC rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Autoimmune Technologies, LLC ranks #25,810 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Autoimmune Technologies, LLC hold?

Autoimmune Technologies, LLC holds 10 US utility patents granted between 2015 and 2021, spanning 7 technology areas.

What is Autoimmune Technologies, LLC's Innovation Score?

Autoimmune Technologies, LLC has an Innovation Score of 26.3 out of 100 (20th percentile of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Autoimmune Technologies, LLC focus on?

Autoimmune Technologies, LLC's top technology area is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations) with 9 patents, ranking #2,057 of 6,058 assignees active in that subclass. Grants appear in 7 CPC subclasses total.

Is Autoimmune Technologies, LLC's patent grant rate increasing or decreasing?

Autoimmune Technologies, LLC's recent grant velocity is -75% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for Autoimmune Technologies, LLC's patents?

Autoimmune Technologies, LLC's patents average 14.4 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Autoimmune Technologies, LLC patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Autoimmune Technologies, LLC

USPTO PatentsView assignee record - 10 granted patents across 7 technology areas, recorded in grant years 2015–2021. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Autoimmune ranks #25,810 of 49,997 tracked US assignees by granted-patent volume, with 10 patents across 7 technology areas.

#25,810
of 49,997 US assignees by volume: 20th percentile
by Innovation Score (26.3/100): 14.4
avg claims per patent: -75%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R25810 · US Corporation #25,810 · 10 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-USCORP · VEL-DROP · BOOK-FULL

GRANTS-MICRO 10 grants
MID-PACK #25,810/49,997
PHOTO-FINISH AUO Display Plus
CPC-NARROW A61P · 7 areas
INNOV-THIN 26.3/100
CLAIMS-RICH 14.4 claims/avg
TYPE-USCORP US Corporation
VEL-DROP -75% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: AUO Display Plus Corporation (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Autoimmune’s 26.3 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 8.3 pts (32%) Velocity 0.0 pts (0%) Breadth 9.4 pts (36%) Claim depth 8.6 pts (33%)

Qualcomm Incorporated · highest

85
Allan Block · near

26
Autoimmune · this assignee

26
Benelli Armi S P A · near

26
DNA Polymerase… · near

26
Thermaltake Technology · near

26
3D Lighting… · lowest

7

What this shows Autoimmune's Innovation Score is 26.3/100 (20th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Autoimmune?

Each dot is one of Autoimmune’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Autoimmune’s own 14.4 claims/patent is ABOVE the 11.8 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Autoimmune vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Autoimmune's grants concentrate

Autoimmune Technologies, LLC is a focused PatentsView assignee: 7 CPC subclasses with 90% of grants classified under A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations). Peak complete grant year is 2015 (2 grants) versus a trough of 1 in 2016. By volume, Autoimmune sits between AUO Display Plus Corporation and Avanzato Technology Corp..

AUO Display Plus

10
Ausculsciences

10
Authentic Vision

10
Autochips Wuhan

10
Autonics

10
Auxocell Laborato…

10
Avant Medical

10
Avanzato Technolo…

10
Autoimmune ◀

10

What this shows Autoimmune holds 10 patents at rank #25,724, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Autoimmune

By rank, the assignees closest to #25,724 in granted patent volume.

Leaders in A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…)

Other assignees with the most granted patents in Autoimmune's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Autoimmune, neither rank-band nor same-CPC leaders (those blocks stay above). In A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…), Autoimmune ranks #2,057 of 6,058 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (26 here).

Thermaltake Technology Co., Ltd. 26 Allan Block, LLC 26 DNA Polymerase Technology, Inc. 26 Benelli Armi S.P.A. 26

Autoimmune's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

26 20th percentile higher than 20% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2021

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Autoimmune Technologies, LLC patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	2	20.0%
2016	1	10.0%
2017	2	20.0%
2018	1	10.0%
2019	2	20.0%
2020	1	10.0%
2021	1	10.0%

Which technologies does Autoimmune Technologies, LLC patent most?

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 9

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 9

C07K - Peptides 9

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 9

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 6

Y02A - Technologies FOR Adaptation TO Climate Change 3

C12Q - Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Microbiological OR Enzymological Processes 2

Top 7 of 7 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Autoimmune Technologies, LLC's patent record in context - here's where to go next.

Autoimmune Technologies, LLC's lead technology class is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations), 90% of its portfolio - see every assignee active in that class. Explore A61P
Ranked #25,810 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Autoimmune Technologies, LLC against AUO Display Plus Corporation, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 26.3/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.